Literature DB >> 2833862

Neutralization of porcine transmissible gastroenteritis virus by complement-dependent monoclonal antibodies.

R D Woods1, R D Wesley, P A Kapke.   

Abstract

Monoclonal antibodies (MAB) to each of the 3 major structural proteins of transmissible gastroenteritis virus (TGEV) of swine were compared, using their virus-neutralizing (VN) activity in the presence or absence of guinea pig, rabbit, or swine complement. The MAB against the peplomer protein had similar VN titers for TGEV in the presence or absence of complement from any source. The MAB against the matrix protein had VN activity for TGEV only in the presence of complement, whereas MAB specific for the nucleocapsid protein did not possess VN activity in the presence or absence of complement. Serum from sows containing antibodies against TGEV peplomer and matrix proteins had slightly higher VN titers in the presence of complement than in the absence of complement. High concentrations of complement from swine serum (128 U) had little effect on the infectivity of TGEV for swine testes cells, whereas 32 U of complement from rabbit serum and 64 U of complement from guinea pig serum were able to neutralize virulent and attenuated TGEV in the absence of known antibodies for TGEV. Complement (less than or equal to 8 U) from any source did not decrease the infectivity of TGEV by greater than 0.5 log10 units.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833862

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  14 in total

1.  Epitope mapping and the detection of transmissible gastroenteritis viral proteins in cell culture using biotinylated monoclonal antibodies in a fixed-cell ELISA.

Authors:  R A Simkins; L J Saif; P A Weilnau
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.

Authors:  H Chen; D M Schifferli
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Development of PCR-based techniques to identify porcine transmissible gastroenteritis coronavirus isolates.

Authors:  R D Woods
Journal:  Can J Vet Res       Date:  1997-07       Impact factor: 1.310

4.  Monoclonal antibodies to a virulent strain of transmissible gastroenteritis virus: comparison of reactivity with virulent and attenuated virus.

Authors:  S K Welch; L J Saif
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.

Authors:  Baochao Fan; Qi Peng; Shiying Song; Danyi Shi; Xue Zhang; Weilu Guo; Yunchuan Li; Jinzhu Zhou; Xuejiao Zhu; Yongxiang Zhao; Rongli Guo; Kongwang He; Huiying Fan; Siyuan Ding; Bin Li
Journal:  J Virol       Date:  2022-08-29       Impact factor: 6.549

6.  Seroconversion of pigs in contact with dogs exposed to canine coronavirus.

Authors:  R D Woods; R D Wesley
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

7.  Identification of a conserved linear B-cell epitope in the M protein of porcine epidemic diarrhea virus.

Authors:  Zhibang Zhang; Jianfei Chen; Hongyan Shi; Xiaojin Chen; Da Shi; Li Feng; Bin Yang
Journal:  Virol J       Date:  2012-10-01       Impact factor: 4.099

8.  The amino-terminal signal peptide on the porcine transmissible gastroenteritis coronavirus matrix protein is not an absolute requirement for membrane translocation and glycosylation.

Authors:  P A Kapke; F Y Tung; B G Hogue; D A Brian; R D Woods; R Wesley
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

9.  Coronavirus immunogens.

Authors:  L J Saif
Journal:  Vet Microbiol       Date:  1993-11       Impact factor: 3.293

10.  Increased litter survival rates, reduced clinical illness and better lactogenic immunity against TGEV in gilts that were primed as neonates with porcine respiratory coronavirus (PRCV).

Authors:  Ronald D Wesley; Kelly M Lager
Journal:  Vet Microbiol       Date:  2003-09-01       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.